Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2025-08-18 00:00:00 ET · period of report 2025-08-15 · accession 0001628280-25-040670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-18 | 2025-08-15 | EBS | Zoon Kathryn C | Dir | S - Sale | $8.87 | -7,086 | 71.8K | -9% | -$62.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-15 | S | D | 7,086 | $8.87 | 71,799 | D | — | — | (F1) Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated May 16, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on May 22, 2025 and May 25, 2025, respectively. (F2) All shares sold at an exact price of $8.87. |